Charles Schwab Investment Management Inc Bionano Genomics, Inc. Transaction History

Charles Schwab Investment Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.57 - $1.16 $505,823 - $1.03 Million	-887,410 Reduced 40.57%	1,299,894 $792,000
Q1 2023 May 11, 2023	SELL	$1.06 - $1.97 $12,852 - $23,886	-12,125 Reduced 0.55%	2,187,304 $2.43 Million
Q4 2022 Feb 13, 2023	BUY	$1.4 - $25.4 $111,721 - $2.03 Million	79,801 Added 3.76%	2,199,429 $3.21 Million
Q3 2022 Nov 14, 2022	BUY	$0.36 - $36.0 $12,981 - $1.3 Million	36,060 Added 1.73%	2,119,628 $3.88 Million
Q2 2022 Aug 15, 2022	SELL	$12.3 - $27.3 $301,952 - $670,187	-24,549 Reduced 1.16%	2,083,568 $2.88 Million
Q1 2022 May 13, 2022	BUY	$16.6 - $32.3 $982,952 - $1.91 Million	59,214 Added 2.89%	2,108,117 $5.44 Million
Q4 2021 Feb 11, 2022	BUY	$29.9 - $61.2 $3.19 Million - $6.54 Million	106,841 Added 5.5%	2,048,903 $6.13 Million
Q3 2021 Nov 16, 2021	BUY	$51.4 - $68.2 $63.8 Million - $84.7 Million	1,241,392 Added 177.17%	1,942,062 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$44.1 - $84.0 $28 Million - $53.3 Million	634,170 Added 953.64%	700,670 $5.14 Million
Q1 2021 May 17, 2021	BUY	$47.0 - $155.7 $3.13 Million - $10.4 Million	66,500 New	66,500 $538,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.